G protein coupled receptors as allosteric proteins and the role of allosteric modulators
- PMID: 20858023
- DOI: 10.3109/10799893.2010.503964
G protein coupled receptors as allosteric proteins and the role of allosteric modulators
Abstract
Seven transmembrane receptors (7TMRs) are proteins that convey signals through changes in conformation. These conformations are stabilized by external molecules (i.e. agonists, antagonists, modulators) and act upon other bodies (termed 'guests') which can be other molecules in the extracellular space, or proteins along the plane of the membrane (receptor oligomerization) or signaling proteins in the cytosol (i.e. G protein, β-arrestin). These elements comprise allosteric systems and a great deal of 7TMR pharmacology can be considered in terms of allosteric behavior. Allosteric ligands acting on 7TMRs possess four unique behaviors that can be valuable therapeutically; (1) the ability to alter the interaction of very large proteins, (2) probe dependence, (3) saturable effect, and (4) induction of separate changes in affinity and efficacy of other ligands. Two of these behaviors (namely probe dependence for CCR5-based HIV-1 entry inhibitors and functional selectivity for biased agonism) will be highlighted with examples.
Similar articles
-
The role of conformational ensembles of seven transmembrane receptors in functional selectivity.Curr Opin Pharmacol. 2010 Dec;10(6):775-81. doi: 10.1016/j.coph.2010.09.004. Curr Opin Pharmacol. 2010. PMID: 20933468 Review.
-
When simple agonism is not enough: emerging modalities of GPCR ligands.Mol Cell Endocrinol. 2011 Jan 15;331(2):241-7. doi: 10.1016/j.mce.2010.07.009. Epub 2010 Jul 21. Mol Cell Endocrinol. 2011. PMID: 20654693 Review.
-
Allosteric properties of G protein-coupled receptor oligomers.Pharmacol Ther. 2007 Sep;115(3):410-8. doi: 10.1016/j.pharmthera.2007.06.004. Epub 2007 Jun 27. Pharmacol Ther. 2007. PMID: 17655934 Review.
-
Allosteric modulation of G protein-coupled receptors: perspectives and recent developments.Drug Discov Today. 2004 Sep 1;9(17):752-8. doi: 10.1016/S1359-6446(04)03220-9. Drug Discov Today. 2004. PMID: 15450241 Review.
-
Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors.Trends Pharmacol Sci. 2007 Aug;28(8):407-15. doi: 10.1016/j.tips.2007.06.009. Epub 2007 Jul 13. Trends Pharmacol Sci. 2007. PMID: 17629960 Review.
Cited by
-
Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior.J Neurosci. 2013 Jan 23;33(4):1615-30. doi: 10.1523/JNEUROSCI.2656-12.2013. J Neurosci. 2013. PMID: 23345234 Free PMC article.
-
Development of allosteric modulators of GPCRs for treatment of CNS disorders.Neurobiol Dis. 2014 Jan;61:55-71. doi: 10.1016/j.nbd.2013.09.013. Epub 2013 Sep 27. Neurobiol Dis. 2014. PMID: 24076101 Free PMC article. Review.
-
Advances in the allostery of angiotensin II type 1 receptor.Cell Biosci. 2023 Jun 17;13(1):110. doi: 10.1186/s13578-023-01063-x. Cell Biosci. 2023. PMID: 37330563 Free PMC article. Review.
-
Differential Activity of Orthosteric Agonists and Allosteric Modulators at Metabotropic Glutamate Receptor 7.Mol Pharmacol. 2023 Jul;104(1):17-27. doi: 10.1124/molpharm.123.000678. Epub 2023 Apr 27. Mol Pharmacol. 2023. PMID: 37105671 Free PMC article.
-
Probe Confined Dynamic Mapping for G Protein-Coupled Receptor Allosteric Site Prediction.ACS Cent Sci. 2021 Nov 24;7(11):1847-1862. doi: 10.1021/acscentsci.1c00802. Epub 2021 Sep 28. ACS Cent Sci. 2021. PMID: 34841058 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources